泛海集團及泛海酒店出售佳兆業證券
泛海國際集團(00129.HK)公布,於2020年4月15日及16日,泛海國際出售人及泛海酒店(00292.HK)出售人分別在公開市場上出售佳兆業(01638.HK)證券,總代價約為94萬美元(相等於約733萬港元)及約為1,210萬美元(相等於約9,438萬港元)。
公司指,出售事項將為泛海國際集團及泛海酒店集團各自提供變現其於佳兆業證券投資之機會,並可於其他再投資機會出現時重新分配資源。
於本財政年度,匯漢集團、泛海國際集團及泛海酒店集團預期將因出售事項錄得除稅前及非控股權益前的收益分別約為619萬港元、約為619萬港元及約為574萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.